Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2020

07.11.2019 | Epidemiology

Flat epithelial atypia: are we being too aggressive?

verfasst von: Ashley DiPasquale, Sveta Silverman, Erene Farag, Lashan Peiris

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The malignant upgrade rate of flat epithelial atypia (FEA) diagnosed on core needle biopsy varies between 0 and 30%. Excision versus observation with radiological follow-up for these lesions remains controversial. We hypothesize that the local rate of FEA is low and that close radiological surveillance is a reasonable treatment option for patients diagnosed with pure FEA on breast needle core needle biopsy.

Methods

This study was a retrospective review of a prospectively collated provincial pathology database. Patients diagnosed with FEA alone on needle core biopsy between 2006 and 2016 were included in our analysis. Patients who had FEA present together with either in situ or invasive carcinoma within the same biopsy cores were excluded. Along with patient demographics, the size of the lesion on preoperative imaging, the method of extraction, and the presence of co-existing benign and malignant pathology on final excision biopsy were analyzed. An independent pathological review was performed to confirm our results and help reduce inter-observer bias.

Results

The local rate of malignant upgrade when pure FEA is diagnosed on a breast needle core biopsy is 12%. Age at time of diagnosis, size of original lesion on mammogram, presence of atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia on core needle biopsy, the use of vacuum-assisted biopsy (VAB), or concordant imaging did not significantly correlate with malignant upgrade risk. None of the patients who were managed with radiological follow-up had malignant upgrade during follow-up. Patients undergoing radiological follow-up alone were more likely to have a VAB, concordant imaging, and no concurrent ADH.

Conclusion

Our local malignant upgrade rate is consistent with published literature. We suggest radiological follow-up is a safe alternative in patients with pure flat epithelial atypia and concordant imaging, particularly those patients with small lesions in which microcalcifications can be removed completely with vacuum-assisted biopsy.
Literatur
7.
Zurück zum Zitat Eusebi V, Feudale E, Foschini MP, Micheli A, Conti A, Riva C, DiPalma S, Rilke F (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11(3):223–235PubMed Eusebi V, Feudale E, Foschini MP, Micheli A, Conti A, Riva C, DiPalma S, Rilke F (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11(3):223–235PubMed
18.
Zurück zum Zitat Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2016) Canadian Cancer Statistics 2016. Canadian Cancer Society, Toronto Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2016) Canadian Cancer Statistics 2016. Canadian Cancer Society, Toronto
25.
Zurück zum Zitat Ferrini R, Mannino E, Ramsdell E, Hill L (1996) Screening mammography for breast cancer: American College of preventive medicine practice policy statement. Am J Prev Med 12(5):340–341CrossRef Ferrini R, Mannino E, Ramsdell E, Hill L (1996) Screening mammography for breast cancer: American College of preventive medicine practice policy statement. Am J Prev Med 12(5):340–341CrossRef
27.
Zurück zum Zitat McCroskey Z, Sneige N, Herman CR, Miller RA, Venta LA, Ro JY, Schwartz MR, Ayala AG (2018) Flat epithelial atypia in directional vacuum-assisted biopsy of breast microcalcifications: surgical excision may not be necessary. Mod Pathol 31:1097–1106CrossRef McCroskey Z, Sneige N, Herman CR, Miller RA, Venta LA, Ro JY, Schwartz MR, Ayala AG (2018) Flat epithelial atypia in directional vacuum-assisted biopsy of breast microcalcifications: surgical excision may not be necessary. Mod Pathol 31:1097–1106CrossRef
Metadaten
Titel
Flat epithelial atypia: are we being too aggressive?
verfasst von
Ashley DiPasquale
Sveta Silverman
Erene Farag
Lashan Peiris
Publikationsdatum
07.11.2019
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05481-9

Weitere Artikel der Ausgabe 2/2020

Breast Cancer Research and Treatment 2/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.